Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A skin marker for geriatric cancer.

P J Muelleman, H O Perry

    Geriatrics
    |April 1, 1986
    PubMed
    Summary

    Dermatomyositis requires differentiation from other conditions like lupus. Initial treatment involves corticosteroids and immunosuppressives to manage inflammation, with underlying malignancy treatment often improving symptoms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Wet- and dry-season steroid hormone profiles and stress reactivity of an insular dwarf snake, the Hog Island boa (Boa constrictor imperator).

    Physiological and biochemical zoology : PBZ·2014
    Same author

    Why a dermatologic consultation?

    Cutis·1999
    Same author

    Malignant pyodermas revisited.

    Mayo Clinic proceedings·1997
    Same author

    Pyoderma gangrenosum: classification and management.

    Journal of the American Academy of Dermatology·1996
    Same author

    Olmsted syndrome.

    Seminars in dermatology·1995
    Same author

    Direct access to dermatologic care is desirable.

    Cutis·1995

    Area of Science:

    • Rheumatology and Dermatology
    • Autoimmune Diseases
    • Dermatopathology

    Background:

    • Dermatomyositis is an idiopathic inflammatory myopathy characterized by muscle weakness and characteristic skin rashes.
    • Differential diagnosis is crucial as dermatomyositis shares features with other autoimmune and dermatological conditions.
    • Malignancy can be associated with dermatomyositis, necessitating its investigation and management.

    Purpose of the Study:

    • To outline the key differential diagnoses for dermatomyositis.
    • To describe the initial management strategies for dermatomyositis.
    • To highlight the relationship between dermatomyositis and underlying malignancies.

    Main Methods:

    • Literature review of dermatomyositis diagnosis and treatment.
    • Comparative analysis of dermatomyositis with similar conditions.
    • Summary of current therapeutic guidelines for dermatomyositis.

    Main Results:

    • Key conditions to differentiate include lupus erythematosus, myxedema, and contact dermatitis.
    • Mixed connective-tissue disease can present with proximal myopathy and skin findings similar to dermatomyositis.
    • Effective treatment of associated malignancies often leads to improved dermatomyositis control.

    Conclusions:

    • Accurate differentiation of dermatomyositis from mimics is essential for appropriate patient care.
    • High-dose corticosteroids and oral immunosuppressives are the cornerstone of initial dermatomyositis treatment.
    • Addressing underlying malignancy is a critical aspect of managing dermatomyositis in affected patients.

    Related Experiment Videos